当前位置:首页 - 行情中心 - 人福医药(600079) - 财务分析 - 现金流量表

人福医药

(600079)

  

流通市值:325.30亿  总市值:344.07亿
流通股本:15.43亿   总股本:16.32亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金11,344,947,942.835,303,884,585.0324,143,262,438.2717,907,290,319.58
  收到的税费返还58,573,906.5326,430,476.8195,326,630.1775,388,365.61
  收到其他与经营活动有关的现金228,831,022.04117,301,969.89458,703,965.73326,007,646.44
  经营活动现金流入小计11,632,352,871.45,447,617,031.7324,697,293,034.1718,308,686,331.63
  购买商品、接受劳务支付的现金5,417,218,551.922,749,877,070.7812,257,696,998.428,955,098,813.88
  支付给职工以及为职工支付的现金1,880,514,323.341,254,794,780.053,370,452,761.582,716,275,940.47
  支付的各项税费1,047,916,745.19502,050,642.771,967,699,324.781,522,844,139.22
  支付其他与经营活动有关的现金2,428,311,413.721,277,674,178.764,937,178,889.93,621,788,984.98
  经营活动现金流出小计10,773,961,034.175,784,396,672.3622,533,027,974.6816,816,007,878.55
  经营活动产生的现金流量净额858,391,837.23-336,779,640.632,164,265,059.491,492,678,453.08
二、投资活动产生的现金流量:
  收回投资收到的现金5,457,778.16373,391.2856,106,178.3653,144,375.55
  取得投资收益收到的现金2,263,297.68777,90031,340,550.0429,173,034.96
  处置固定资产、无形资产和其他长期资产收回的现金净额6,629,244.215,179,210.4136,183,79431,551,767.17
  处置子公司及其他营业单位收到的现金净额46,300,0002,900,000220,619,202.5278,541,579.19
  收到的其他与投资活动有关的现金57,320,422.12-138,687,50076,937,500
  投资活动现金流入小计117,970,742.179,230,501.69482,937,224.92269,348,256.87
  购建固定资产、无形资产和其他长期资产支付的现金380,636,508.28249,050,876.061,020,943,995.37794,874,603.43
  投资支付的现金--6,750,0005,000,000
  取得子公司及其他营业单位支付的现金--53,039,279.9253,231,097.19
  支付其他与投资活动有关的现金45,158,691.33-144,229,056.7104,103,278.7
  投资活动现金流出小计425,795,199.61249,050,876.061,224,962,331.99957,208,979.32
  投资活动产生的现金流量净额-307,824,457.44-239,820,374.37-742,025,107.07-687,860,722.45
三、筹资活动产生的现金流量:
  吸收投资收到的现金--18,010,0008,540,000
  其中:子公司吸收少数股东投资收到的现金--18,010,0008,540,000
  取得借款收到的现金5,239,810,0002,257,490,0009,348,149,069.226,570,205,069.22
  收到其他与筹资活动有关的现金174,205,255.5577,739,393.43494,776,099.48318,656,657.15
  筹资活动现金流入小计5,414,015,255.552,335,229,393.439,860,935,168.76,897,401,726.37
  偿还债务支付的现金4,768,818,731.691,913,455,029.429,440,221,160.496,383,972,622.02
  分配股利、利润或偿付利息支付的现金461,461,009.5111,452,680.241,390,240,847.571,102,039,051.24
  其中:子公司支付给少数股东的股利、利润53,353,198.823,164,378.32120,931,806.9110,696,241.24
  支付其他与筹资活动有关的现金278,439,128.22129,147,679.63528,470,522.67375,461,722.67
  筹资活动现金流出小计5,508,718,869.412,154,055,389.2911,358,932,530.737,861,473,395.93
  筹资活动产生的现金流量净额-94,703,613.86181,174,004.14-1,497,997,362.03-964,071,669.56
四、汇率变动对现金及现金等价物的影响14,449,373.586,805,021.75-23,866,875.3-42,337,124.54
五、现金及现金等价物净增加额470,313,139.51-388,620,989.11-99,624,284.91-201,591,063.47
  加:期初现金及现金等价物余额2,890,820,258.262,890,820,258.262,990,444,543.172,990,444,543.17
  期末现金及现金等价物余额3,361,133,397.772,502,199,269.152,890,820,258.262,788,853,479.7
补充资料:
  净利润1,497,174,002.51-1,778,342,930.44-
  资产减值准备18,073,491.14-393,861,278.28-
  固定资产和投资性房地产折旧386,911,578.97-759,401,492.1-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧386,911,578.97-759,401,492.1-
  无形资产摊销108,655,363.79-242,492,192.99-
  长期待摊费用摊销6,053,285.79-17,543,227.89-
  处置固定资产、无形资产和其他长期资产的损失351,249.07-4,472,024.18-
  固定资产报废损失533,663.28-11,821,590.41-
  公允价值变动损失1,618,385.31--112,716,765.01-
  财务费用137,045,343.04-336,704,934.23-
  投资损失-53,340,903.96--143,838,770.49-
  递延所得税-9,586,365.84-658,265.46-
  其中:递延所得税资产减少-2,731,439.24--6,631,221.33-
    递延所得税负债增加-6,854,926.6-7,289,486.79-
  存货的减少116,540,501.93--459,024.88-
  经营性应收项目的减少-600,646,680.02--764,553,123.28-
  经营性应付项目的增加-799,518,953.98--679,476,910.52-
  其他--13,273,361.22-
  现金的期末余额3,361,133,397.77-2,890,820,258.26-
  减:现金的期初余额2,890,820,258.26-2,990,444,543.17-
  现金及现金等价物的净增加额470,313,139.51--99,624,284.91-
公告日期2025-08-282025-04-292025-04-292024-10-30
审计意见(境内)带强调事项段的无保留意见
TOP↑